Literature DB >> 18770028

Approaches to prevent dopamine quinone-induced neurotoxicity.

Ikuko Miyazaki1, Masato Asanuma.   

Abstract

Dopamine (DA) and its metabolites containing two hydroxyl residues exert cytotoxicity in dopaminergic neuronal cells, primarily due to the generation of highly reactive DA and DOPA quinones. Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the ubiquitin-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and methamphetamine-induced neurotoxicity. Therefore, pathogenic effects of the DA quinone have focused on dopaminergic neuron-specific oxidative stress. Recently, various studies have demonstrated that some intrinsic molecules and several drugs exert protective effects against DA quinone-induced damage of dopaminergic neurons. In this article, we review recent studies on some neuroprotective approaches against DA quinone-induced dysfunction and/or degeneration of dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770028     DOI: 10.1007/s11064-008-9843-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  90 in total

Review 1.  Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.

Authors:  Masato Asanuma; Ikuko Miyazaki; Francisco J Diaz-Corrales; Norio Ogawa
Journal:  Acta Med Okayama       Date:  2004-10       Impact factor: 0.892

2.  L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.

Authors:  Yuko Yoshimoto; Kazuhiro Nakaso; Kenji Nakashima
Journal:  FEBS Lett       Date:  2005-01-21       Impact factor: 4.124

Review 3.  Metallothioneins are multipurpose neuroprotectants during brain pathology.

Authors:  Milena Penkowa
Journal:  FEBS J       Date:  2006-05       Impact factor: 5.542

4.  Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice.

Authors:  B Ferger; P Teismann; C D Earl; K Kuschinsky; W H Oertel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-09       Impact factor: 3.000

5.  Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

Authors:  G P Lim; F Yang; T Chu; P Chen; W Beech; B Teter; T Tran; O Ubeda; K H Ashe; S A Frautschy; G M Cole
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

6.  Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.

Authors:  Ikuko Miyazaki; Masato Asanuma; Francisco J Diaz-Corrales; Masaya Fukuda; Kiyoyuki Kitaichi; Ko Miyoshi; Norio Ogawa
Journal:  FASEB J       Date:  2006-01-10       Impact factor: 5.191

7.  Dopamine induces proteasome inhibition in neural PC12 cell line.

Authors:  J N Keller; F F Huang; E R Dimayuga; W F Maragos
Journal:  Free Radic Biol Med       Date:  2000-11-15       Impact factor: 7.376

8.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

Review 9.  Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.

Authors:  Taizo Kita; George C Wagner; Toshikatsu Nakashima
Journal:  J Pharmacol Sci       Date:  2003-07       Impact factor: 3.337

10.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more
  29 in total

Review 1.  Prerequisites for ubiquinone analogs to prevent mitochondrial permeability transition-induced cell death.

Authors:  Julie Belliere; Flavien Devun; Cécile Cottet-Rousselle; Cécile Batandier; Xavier Leverve; Eric Fontaine
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

Review 2.  Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.

Authors:  Yanwei Li; Jinying Zhao; Christian Hölscher
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

Review 3.  Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Authors:  Faneng Sun; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

4.  Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells.

Authors:  M Lin; P Chandramani-Shivalingappa; H Jin; A Ghosh; V Anantharam; S Ali; A G Kanthasamy; A Kanthasamy
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

5.  Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response.

Authors:  Rahul Srinivasan; Christopher I Richards; Cheng Xiao; Doreen Rhee; Rigo Pantoja; Dennis A Dougherty; Julie M Miwa; Henry A Lester
Journal:  Mol Pharmacol       Date:  2012-02-29       Impact factor: 4.436

6.  Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.

Authors:  Che Brown Hutson; Carlos R Lazo; Farzad Mortazavi; Christopher C Giza; David Hovda; Marie-Francoise Chesselet
Journal:  J Neurotrauma       Date:  2011-09       Impact factor: 5.269

7.  Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.

Authors:  Sarah E A McConnell; M Kerry O'Banion; Deborah A Cory-Slechta; John A Olschowka; Lisa A Opanashuk
Journal:  Neurotoxicology       Date:  2015-08-15       Impact factor: 4.294

8.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

9.  Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.

Authors:  Masoome Khalife; Dina Morshedi; Farhang Aliakbari; Amir Tayaranian Marvian; Hossein Mohammad Beigi; Sadegh Azimzadeh Jamalkandi; Francisco Pan-Montojo
Journal:  Protein J       Date:  2015-08       Impact factor: 2.371

Review 10.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Authors:  Takumi Satoh; Scott R McKercher; Stuart A Lipton
Journal:  Free Radic Biol Med       Date:  2013-07-25       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.